$SDCH
SideChannel, Inc. Stock $sdch

$sdch Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000149315223046278 Filed on December 27, 2023

Income Statement

Concept	2023 Q3	2023	2022
Revenue	$1.659M	$6.572M	$4.789M
YoY Change	-65.35%	37.23%	23845.0%
Cost Of Revenue	$803.0K	$3.240M	$2.468M
YoY Change	-67.46%	31.28%
Gross Profit	$856.0K	$3.332M	$2.321M
YoY Change	-63.11%	43.56%	11505.0%
Gross Profit Margin	51.6%	50.7%	48.47%
Selling, General & Admin	$985.0K	$4.923M	$1.849M
YoY Change	-288.46%	166.25%	-31.26%
% of Gross Profit	115.07%	147.75%	79.66%
Research & Development	$186.0K	$669.0K	$178.0K
YoY Change	-165.53%	275.84%	-71.29%
% of Gross Profit	21.73%	20.08%	7.67%
Depreciation & Amortization	$2.000K	$2.000K	$46.00K
YoY Change	-95.65%	-95.65%
% of Gross Profit	0.23%	0.06%	1.98%
Operating Expenses	$1.171M	$10.75M	$13.92M
YoY Change	-245.2%	-22.77%	320.39%
Operating Profit	-$315.0K	-$7.414M	-$11.59M
YoY Change	-110.07%	-36.05%	252.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$7.000K	$29.00K	$13.00K
YoY Change	-46.15%	123.08%	333.33%
Pretax Income	-$5.248M	-$7.385M	-$11.58M
YoY Change	-40.01%	-36.23%	273.58%
Income Tax	-$379.0K	-$379.0K	$195.0K
% Of Pretax Income
Net Earnings	-$4.869M	-$7.006M	-$11.78M
YoY Change	-45.56%	-40.51%	279.87%
Net Earnings / Revenue	-293.49%	-106.6%	-245.9%
Basic Earnings Per Share		-$0.04	-$0.14
Diluted Earnings Per Share	-$0.02	-$0.04	-$0.14
COMMON SHARES
Basic Shares Outstanding	213.6M shares	175.3M shares	82.00M shares
Diluted Shares Outstanding		175.3M shares	82.00M shares

Balance Sheet

Concept	2023 Q3	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.053M	$1.053M	$3.030M
YoY Change	-65.25%	-65.25%	-47.58%
Cash & Equivalents	$1.100M		$3.030M
Short-Term Investments
Other Short-Term Assets	$561.0K	$561.0K	$500.0K
YoY Change	12.2%	12.2%	8.7%
Inventory
Prepaid Expenses	$381.0K
Receivables	$834.0K	$834.0K	$612.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.448M	$2.448M	$4.142M
YoY Change	-40.9%	-40.9%	-33.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.00K	$30.00K
YoY Change
Goodwill	$1.356M
YoY Change	-3.14%
Intangibles	$0.00
YoY Change	-100.0%
Long-Term Investments
YoY Change
Other Assets	$150.0K	$150.0K	$330.0K
YoY Change	-54.55%	-54.55%	-35.29%
Total Long-Term Assets	$1.536M	$1.536M	$6.626M
YoY Change	-76.82%	-76.82%	1199.22%
TOTAL ASSETS
Total Short-Term Assets	$2.448M	$2.448M	$4.142M
Total Long-Term Assets	$1.536M	$1.536M	$6.626M
Total Assets	$3.984M	$3.984M	$10.77M
YoY Change	-63.0%	-63.0%	59.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$613.0K	$613.0K	$786.0K
YoY Change	-22.01%	-22.01%	-46.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$50.00K	$50.00K	$50.00K
YoY Change	0.0%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$954.0K	$954.0K	$1.161M
YoY Change	-17.83%	-17.83%	-22.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$954.0K	$954.0K	$1.161M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$954.0K	$954.0K	$1.372M
YoY Change	-30.47%	-30.47%	-7.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.94M
YoY Change	58.71%
Common Stock	$214.0K
YoY Change	43.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.030M	$3.030M	$9.396M
YoY Change
Total Liabilities & Shareholders Equity	$3.984M	$3.984M	$10.77M
YoY Change	-63.0%	-63.0%	59.53%

Cashflow Statement

Concept	2023 Q3	2023	2022
OPERATING ACTIVITIES
Net Income	-$4.869M	-$7.006M	-$11.78M
YoY Change	-45.56%	-40.51%	279.87%
Depreciation, Depletion And Amortization	$2.000K	$2.000K	$46.00K
YoY Change	-95.65%	-95.65%
Cash From Operating Activities	-$385.0K	-$1.945M	-$396.0K
YoY Change	-121.4%	391.16%	-89.09%
INVESTING ACTIVITIES
Capital Expenditures	$8.000K	$32.00K
YoY Change
Acquisitions			-$3.589M
YoY Change
Other Investing Activities	$0.00	$0.00	$3.589M
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$8.000K	-$32.00K	$3.589M
YoY Change	-100.22%	-100.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000		-$511.0K
YoY Change	-100.0%		-106.13%
NET CHANGE
Cash From Operating Activities	-385.0K	-$1.945M	-$396.0K
Cash From Investing Activities	-8.000K	-$32.00K	$3.589M
Cash From Financing Activities	0.000		-$511.0K
Net Change In Cash	-393.0K	-$1.977M	$2.682M
YoY Change	-108.06%	-173.71%
FREE CASH FLOW
Cash From Operating Activities	-$385.0K	-$1.945M	-$396.0K
Capital Expenditures	$8.000K	$32.00K
Free Cash Flow	-$393.0K	-$1.977M	-$396.0K
YoY Change		399.24%	-89.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001022505
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	SDCH	Increase Decrease In Unbilled Revenue IncreaseDecreaseInUnbilledRevenue		usd
CY2022	SDCH	Increase Decrease In Unbilled Revenue IncreaseDecreaseInUnbilledRevenue		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	SDCH	Equity Redemptions Related To Financing Activies EquityRedemptionsRelatedToFinancingActivies		usd
CY2023	SDCH	Equity Distributions Related To Financing Activies EquityDistributionsRelatedToFinancingActivies		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	SDCH	Equity Redemption With Note Payable EquityRedemptionWithNotePayable		usd
CY2022	SDCH	Stock Based Compensation Included In Accounts Payable And Accrued Liabilities StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities		usd
CY2023	SDCH	Assets Acquired And Liabilities Assumed AssetsAcquiredAndLiabilitiesAssumed		usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022Q3	SDCH	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceExercised
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	SDCH	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceExercised
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes		pure
CY2022	SDCH	Effective Income Tax Rate Reconciliation Nondeductible Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleMealsAndEntertainment		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-28745
CY2023	dei	Entity Registrant Name EntityRegistrantName	SideChannel, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0837077
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	146 Main Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 405
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Worcester
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01608
CY2023	dei	City Area Code CityAreaCode	(508)
CY2023	dei	Local Phone Number LocalPhoneNumber	925-0114
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	7800000	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	214117267	shares
CY2023	dei	Auditor Firm AuditorFirmId	587
CY2023	dei	Auditor Name AuditorName	RBSM LLP
CY2023	dei	Auditor Location AuditorLocation	Las Vegas, Nevada
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1053000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3030000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	834000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	612000	usd
CY2023Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	180000	usd
CY2022Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	180000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	381000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	320000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2448000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	4142000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1356000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1356000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4940000	usd
CY2023Q3	us-gaap	Deferred Costs DeferredCosts	150000	usd
CY2022Q3	us-gaap	Deferred Costs DeferredCosts	330000	usd
CY2023Q3	us-gaap	Assets Assets	3984000	usd
CY2022Q3	us-gaap	Assets Assets	10768000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	613000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	786000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	280000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	130000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	50000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	50000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	11000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	195000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	954000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1161000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	211000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	954000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1372000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	681000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	681000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	213854781	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	213854781	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	148724056	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	148724056	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	214000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	149000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21755000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21180000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18939000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11933000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3030000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9396000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3984000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10768000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6572000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4789000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3240000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2468000	usd
CY2023	us-gaap	Gross Profit GrossProfit	3332000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2321000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3586000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1482000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1337000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	367000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	669000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5702000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4940000	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	214000	usd
CY2022	us-gaap	Acquisition Costs AcquisitionCosts	6186000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10746000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	13915000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7414000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11594000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7385000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11581000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-379000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-7006000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11776000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	175274762	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	175274762	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81997953	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81997953	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	427000	usd
CY2022	SDCH	Equity Redemptions EquityRedemptions	-100000	usd
CY2022	SDCH	Equity Distributions EquityDistributions	-461000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	43000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	30000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	6061000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	15172000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11776000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9396000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9396000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	360000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	214000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-7006000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3030000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3030000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-7006000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11776000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	182000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	405000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	73000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	214000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6061000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5702000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4940000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	225000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	461000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	61000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-15000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-547000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-18000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	150000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-65000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1945000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-396000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-3589000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3589000	usd
CY2022	SDCH	Equity Redemptions Related To Financing Activies EquityRedemptionsRelatedToFinancingActivies	50000	usd
CY2022	SDCH	Equity Distributions Related To Financing Activies EquityDistributionsRelatedToFinancingActivies	461000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-511000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1977000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2682000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3030000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	348000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1053000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3030000	usd
CY2023	SDCH	Shares Issued For Services Non Cash Investing And Financing Activities SharesIssuedForServicesNonCashInvestingAndFinancingActivities	66000	usd
CY2022	SDCH	Shares Issued For Services Non Cash Investing And Financing Activities SharesIssuedForServicesNonCashInvestingAndFinancingActivities	43000	usd
CY2022	SDCH	Equity Redemption With Note Payable EquityRedemptionWithNotePayable	50000	usd
CY2023	SDCH	Stock Based Compensation Included In Accounts Payable And Accrued Liabilities StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities	21000	usd
CY2022	SDCH	Assets Acquired And Liabilities Assumed AssetsAcquiredAndLiabilitiesAssumed	11583000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zuNwXj0uaBG2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zXUUn2Lv9Ke2">Reclassifications</span></b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	800000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35000000	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	4900000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7000000.0	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	211000	usd
CY2022Q3	us-gaap	Goodwill Fair Value Disclosure GoodwillFairValueDisclosure	5702000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5700000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1400000	usd
CY2023Q3	SDCH	Percentage Of Accounts Receivable PercentageOfAccountsReceivable	0.03	pure
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	669000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	82000000.0	shares
CY2023Q3	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q3	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q3	SDCH	Milestone Revenue MilestoneRevenue	5500000	usd
CY2022Q3	us-gaap	Share Price SharePrice	0.10
CY2022Q3	SDCH	Fair Value Of Closing Shares FairValueOfClosingShares	6100000	usd
CY2022Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	88400000	usd
CY2022Q3	us-gaap	Share Price SharePrice	0.101
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6200000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	280000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	130000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	130000	usd
CY2023	SDCH	Contract With Customer Liability Revenue Deferred ContractWithCustomerLiabilityRevenueDeferred	553000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	403000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	280000	usd
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	194000	usd
CY2022	SDCH	Contract With Customer Liability Revenue Deferred ContractWithCustomerLiabilityRevenueDeferred	107000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	171000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	130000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12000	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022	us-gaap	Limited Partners Capital Account Distribution Amount LimitedPartnersCapitalAccountDistributionAmount	461000	usd
CY2021Q4	us-gaap	Limited Partners Capital Account Distribution Amount LimitedPartnersCapitalAccountDistributionAmount	0	usd
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	213854781	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	148724056	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	681000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	2116618	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8000000.0	shares
CY2021Q3	SDCH	Reserve Percentage ReservePercentage	0.05	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8186106	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.10
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	694000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y3M18D
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	87794000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.56
CY2022Q3	SDCH	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P3Y9M25D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	87794000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.56
CY2023	SDCH	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P3Y6M25D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	18513000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.20
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	69281000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.39
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y3M21D
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-136000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	136000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-32000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	59000	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-168000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	195000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-211000	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-211000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-379000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	SDCH	Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration	-0.0189	pure
CY2022	SDCH	Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration	-0.0872	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.0814	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0010	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.0158	pure
CY2023	SDCH	Effective Income Tax Rate Reconciliation Nondeductible Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleMealsAndEntertainment	-0.0022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0302	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0080	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1836	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0484	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0513	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-379000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	27000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	211000	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	36200000	usd
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	525000	usd
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. Future ownership changes may trigger Section 382 and therefore, substantially limit the amount of pre-Combination NOLs that can be utilized annually to offset future taxable income.

Files In Submission

Name	View Source	Status
sdch-20230930_lab.xml	Edgar Link	unprocessable
sdch-20230930_pre.xml	Edgar Link	unprocessable
sdch-20230930_def.xml	Edgar Link	unprocessable
sdch-20230930_cal.xml	Edgar Link	unprocessable
0001493152-23-046278-index-headers.html	Edgar Link	pending
0001493152-23-046278-index.html	Edgar Link	pending
0001493152-23-046278.txt	Edgar Link	pending
0001493152-23-046278-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sdch-20230930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SDCH
SideChannel, Inc. Stock $sdch

2023 Q3 Form 10-K Financial Statement

#000149315223046278 Filed on December 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SDCH SideChannel, Inc. Stock $sdch

2023 Q3 Form 10-K Financial Statement

#000149315223046278 Filed on December 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SDCH
SideChannel, Inc. Stock $sdch